Search alternatives:
largest decrease » marked decrease (Expand Search)
linear decrease » linear increase (Expand Search)
larger decrease » marked decrease (Expand Search)
Showing 621 - 640 results of 2,079 for search 'significantly ((((linear decrease) OR (larger decrease))) OR (largest decrease))', query time: 0.57s Refine Results
  1. 621

    Fig 29 in each curve fitting results. by Zhezhe Zhang (19704587)

    Published 2024
    “…Under the same <i>JRC</i>, σ<sub><i>i</i></sub> increases with the increase of τ<sub>1</sub>, and Δσ<sub>n</sub> decreases with the increasing τ<sub>1</sub>. Under the same <i>JRC</i> and σ<sub><i>i</i></sub>, τ<sub><i>i</i></sub> is significantly smaller under the UNLCSL path than the CNL path. …”
  2. 622

    Fig 9(b) in the straight-line fitting results. by Zhezhe Zhang (19704587)

    Published 2024
    “…Under the same <i>JRC</i>, σ<sub><i>i</i></sub> increases with the increase of τ<sub>1</sub>, and Δσ<sub>n</sub> decreases with the increasing τ<sub>1</sub>. Under the same <i>JRC</i> and σ<sub><i>i</i></sub>, τ<sub><i>i</i></sub> is significantly smaller under the UNLCSL path than the CNL path. …”
  3. 623

    Specimen packaging process. by Zhezhe Zhang (19704587)

    Published 2024
    “…Under the same <i>JRC</i>, σ<sub><i>i</i></sub> increases with the increase of τ<sub>1</sub>, and Δσ<sub>n</sub> decreases with the increasing τ<sub>1</sub>. Under the same <i>JRC</i> and σ<sub><i>i</i></sub>, τ<sub><i>i</i></sub> is significantly smaller under the UNLCSL path than the CNL path. …”
  4. 624

    Relationship between τ<sub><i>i</i></sub> and σ<sub><i>i</i></sub>. by Zhezhe Zhang (19704587)

    Published 2024
    “…Under the same <i>JRC</i>, σ<sub><i>i</i></sub> increases with the increase of τ<sub>1</sub>, and Δσ<sub>n</sub> decreases with the increasing τ<sub>1</sub>. Under the same <i>JRC</i> and σ<sub><i>i</i></sub>, τ<sub><i>i</i></sub> is significantly smaller under the UNLCSL path than the CNL path. …”
  5. 625

    The relationship between Δσ<sub>n</sub> and τ<sub>1</sub>, <i>JRC</i>. by Zhezhe Zhang (19704587)

    Published 2024
    “…Under the same <i>JRC</i>, σ<sub><i>i</i></sub> increases with the increase of τ<sub>1</sub>, and Δσ<sub>n</sub> decreases with the increasing τ<sub>1</sub>. Under the same <i>JRC</i> and σ<sub><i>i</i></sub>, τ<sub><i>i</i></sub> is significantly smaller under the UNLCSL path than the CNL path. …”
  6. 626

    Relationship between τ<sub><i>i</i></sub> and σ<sub><i>i</i></sub>. by Zhezhe Zhang (19704587)

    Published 2024
    “…Under the same <i>JRC</i>, σ<sub><i>i</i></sub> increases with the increase of τ<sub>1</sub>, and Δσ<sub>n</sub> decreases with the increasing τ<sub>1</sub>. Under the same <i>JRC</i> and σ<sub><i>i</i></sub>, τ<sub><i>i</i></sub> is significantly smaller under the UNLCSL path than the CNL path. …”
  7. 627
  8. 628
  9. 629
  10. 630

    Flowchart of the screening process. by Huixia Ren (500186)

    Published 2025
    “…Efficacy was assessed through intraoperative outcomes, primary postoperative outcomes, and statistically significant postoperative outcomes. Patients with thyroid disorders undergoing TOTVA experienced longer overall operative time and hospital stays, reduced intraoperative blood loss, increased lymph node retrieval, higher incidence of infection, lower postoperative pain scores, reduced incidence of hypocalcemia, larger drainage volumes, and higher cosmetic effect scores compared with those undergoing.…”
  11. 631

    Result of the AMSTAR-2 assessments. by Huixia Ren (500186)

    Published 2025
    “…Efficacy was assessed through intraoperative outcomes, primary postoperative outcomes, and statistically significant postoperative outcomes. Patients with thyroid disorders undergoing TOTVA experienced longer overall operative time and hospital stays, reduced intraoperative blood loss, increased lymph node retrieval, higher incidence of infection, lower postoperative pain scores, reduced incidence of hypocalcemia, larger drainage volumes, and higher cosmetic effect scores compared with those undergoing.…”
  12. 632

    Characteristics of included reviews. by Huixia Ren (500186)

    Published 2025
    “…Efficacy was assessed through intraoperative outcomes, primary postoperative outcomes, and statistically significant postoperative outcomes. Patients with thyroid disorders undergoing TOTVA experienced longer overall operative time and hospital stays, reduced intraoperative blood loss, increased lymph node retrieval, higher incidence of infection, lower postoperative pain scores, reduced incidence of hypocalcemia, larger drainage volumes, and higher cosmetic effect scores compared with those undergoing.…”
  13. 633

    Result of the PRISMA assessments. by Huixia Ren (500186)

    Published 2025
    “…Efficacy was assessed through intraoperative outcomes, primary postoperative outcomes, and statistically significant postoperative outcomes. Patients with thyroid disorders undergoing TOTVA experienced longer overall operative time and hospital stays, reduced intraoperative blood loss, increased lymph node retrieval, higher incidence of infection, lower postoperative pain scores, reduced incidence of hypocalcemia, larger drainage volumes, and higher cosmetic effect scores compared with those undergoing.…”
  14. 634

    Result of the ROBIS assessments. by Huixia Ren (500186)

    Published 2025
    “…Efficacy was assessed through intraoperative outcomes, primary postoperative outcomes, and statistically significant postoperative outcomes. Patients with thyroid disorders undergoing TOTVA experienced longer overall operative time and hospital stays, reduced intraoperative blood loss, increased lymph node retrieval, higher incidence of infection, lower postoperative pain scores, reduced incidence of hypocalcemia, larger drainage volumes, and higher cosmetic effect scores compared with those undergoing.…”
  15. 635
  16. 636
  17. 637
  18. 638
  19. 639
  20. 640